Latest news
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
June 23, 2022
WILMINGTON, Mass. and GHENT, Belgium - Charles River Laboratories International, Inc. (NYSE: CRL) and Ziphius Vaccines today announced an agreement to manufacture starting materials critical to clinical-stage research.
